American Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.3M Sell
162,110
-3,946
-2% -$2.21M 3.83% 6
2026
Q1
$93.3M Sell
166,056
-15,689
-9% -$10.1M 5.01% 4
2025
Q4
$123M Sell
181,745
-2,553
-1% -$1.74M 5.43% 5
2025
Q3
$118M Sell
184,298
-4,702
-2% -$2.85M 4.69% 5
2025
Q2
$101M Sell
189,000
-32,606
-15% -$15.6M 4.2% 5
2025
Q1
$93.1M Buy
221,606
+15,544
+8% +$6.75M 3.79% 6
2024
Q4
$85.2M Sell
206,062
-42,791
-17% -$18.8M 3.17% 8
2024
Q3
$126M Sell
248,853
-42,414
-15% -$20.6M 4.11% 6
2024
Q2
$142M Sell
291,267
-1,886
-0.6% -$947K 4.75% 5
2024
Q1
$158M Sell
293,153
-9,147
-3% -$5M 5.07% 5
2023
Q4
$168M Sell
302,300
-4,075
-1% -$1.91M 5.74% 4
2023
Q3
$134M Sell
306,375
-24,141
-7% -$12M 5.16% 5
2023
Q2
$166M Sell
330,516
-32,986
-9% -$15.8M 5.76% 3
2023
Q1
$182M Sell
363,502
-19,667
-5% -$9.41M 6.4% 3
2022
Q4
$156M Sell
383,169
-178
-0% -$69.1K 6.12% 3
2022
Q3
$125M Sell
383,347
-1,315
-0.3% -$483K 4.93% 4
2022
Q2
$135M Sell
384,662
-1,995
-0.5% -$814K 5.06% 4
2022
Q1
$212M Sell
386,657
-6,992
-2% -$3.68M 6.24% 2
2021
Q4
$259M Sell
393,649
-355
-0.1% -$223K 6.66% 3
2021
Q3
$245M Sell
394,004
-31,584
-7% -$21.2M 6.58% 3
2021
Q2
$269M Sell
425,588
-1,786
-0.4% -$986K 7.53% 2
2021
Q1
$209M Sell
427,374
-9,284
-2% -$4.65M 6.32% 2
2020
Q4
$218M Sell
436,658
-11,550
-3% -$5.17M 6.53% 2
2020
Q3
$176M Sell
448,208
-25,710
-5% -$9.51M 6.47% 1
2020
Q2
$156M Sell
473,918
-2,020
-0.4% -$585K 5.75% 1
2020
Q1
$115M Sell
475,938
-3,721
-0.8% -$971K 5.61% 1
2019
Q4
$125M Buy
479,659
+570
+0.1% +$150K 5.25% 2
2019
Q3
$130M Sell
479,089
-2,606
-0.5% -$725K 5.77% 1
2019
Q2
$133M Buy
481,695
+7,415
+2% +$1.83M 5.67% 1
2019
Q1
$106M Sell
474,280
-11,170
-2% -$2.31M 4.92% 3
2018
Q4
$90.3M Sell
485,450
-308
-0.1% -$63.1K 4.82% 3
2018
Q3
$121M Sell
485,758
-8,539
-2% -$2.07M 5.3% 3
2018
Q2
$108M Sell
494,297
-10,689
-2% -$2.2M 5.56% 3
2018
Q1
$96.6M Sell
504,986
-15,957
-3% -$2.95M 5.51% 2
2017
Q4
$81.5M Buy
520,943
+3,820
+0.7% +$601K 4.9% 3
2017
Q3
$80.4M Sell
517,123
-2,165
-0.4% -$342K 5.03% 3
2017
Q2
$83.8M Sell
519,288
-53,397
-9% -$8.67M 5.41% 1
2017
Q1
$88.5M Sell
572,685
-6,295
-1% -$868K 6.25% 2
2016
Q4
$67.9M Sell
578,980
-665
-0.1% -$75.9K 5.26% 3
2016
Q3
$65.3M Sell
579,645
-70,261
-11% -$7.41M 5.02% 2
2016
Q2
$60.4M Sell
649,906
-2,460
-0.4% -$211K 4.99% 2
2016
Q1
$51.1M Buy
652,366
+4,510
+0.7% +$325K 4.46% 3
2015
Q4
$47.2M Buy
647,856
+106,310
+20% +$7.58M 4.19% 3
2015
Q3
$40.2M Buy
541,546
+11,410
+2% +$817K 4.17% 4
2015
Q2
$34M Buy
530,136
+16,020
+3% +$1.11M 3.24% 8
2015
Q1
$39.7M Sell
514,116
-10,210
-2% -$795K 3.91% 6
2014
Q4
$38.9M Sell
524,326
-17,760
-3% -$1.25M 4.22% 4
2014
Q3
$31.9M Sell
542,086
-2,300
-0.4% -$145K 3.72% 6
2014
Q2
$36.4M Buy
544,386
+4,850
+0.9% +$308K 4.09% 5
2014
Q1
$32.8M Sell
539,536
-3,660
-0.7% -$218K 3.86% 4
2013
Q4
$28.9M Buy
543,196
+4,296
+0.8% +$226K 3.58% 8
2013
Q3
$26.9M Buy
538,900
+4,640
+0.9% +$223K 3.61% 8
2013
Q2
$24M Buy
+534,260
New +$23.3M 3.6% 6

Other funds holding IDXX

American Capital Management's IDXX Position: Q2 2026 in Review

American Capital Management reduced its Idexx Laboratories (IDXX) stake by 2.4% in Q2 2026, selling an estimated $2.21M and leaving 162,110 shares worth $85.3M. The position accounts for 3.83% of the portfolio, ranked #6.

American Capital Management first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $269M in Q2 2021. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • American Capital Management held 162,110 shares of Idexx Laboratories worth $85.3M as of Q2 2026.
  • American Capital Management sold 3,946 Idexx Laboratories shares in Q2 2026, an estimated $2.21M.
  • Idexx Laboratories made up 3.83% of American Capital Management's portfolio in Q2 2026, its #6 holding.
  • American Capital Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • American Capital Management's Idexx Laboratories position peaked at $269M in Q2 2021.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on American Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.